NiKang Therapeutics
NiKang Therapeutics is a biotech company focused on discovering and developing small molecule oncology medicines.
NiKang Therapeutics operates in biotechnology, health care, medical, oncology based in Greater Philadelphia Area, East Coast, Southern US, founded in 2017.
Within the biotechnology, health care, medical, oncology space, the company focuses on its core offering rather than a broad product line.
Its base of operations is Greater Philadelphia Area, East Coast, Southern US.
The company is listed at the Series_C stage of development.
Recorded headcount: c_00011_00050 employees.
It has disclosed roughly $260M in funding.
| Sector | Biotechnology, Health Care, Medical, Oncology |
|---|---|
| Headquarters | Greater Philadelphia Area, East Coast, Southern US |
| Founded | 2017 |
| Employees | c_00011_00050 |
| Stage | series_c |
| Total funding | $260,000,000 |
Website: www.nikangtx.com
Browse related
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account